Rytary (Carbidopa-Levodopa ER) in Parkinson’s Disease

Rytary (Carbidopa-Levodopa ER) in Parkinson’s Disease

by | Feb 24, 2021 | Medication and Disease State Clinical Pearls For Pharmacists, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls

Parkinson’s disease (PD) has long presented challenges in medication delivery. A staple in more advanced disease control, carbidopa-levodopa requires multiple daily dosing with supratherapeutic levels leading to dyskinesias and subtherapeutic concentrations leading to...